Latest
Recommended
Published: Sun, March 19, 2017
World | By Tasha Manning

Craniosynostosis - Symptoms, Diagnosis, Treatment of Craniosynostosis - NY Times Health Information

Craniosynostosis - Symptoms, Diagnosis, Treatment of Craniosynostosis - NY Times Health Information

FDA approves Elaprase (idursulfase) for Hunter syndrome
Elaprase is manufactured by Shire Human Genetic Therapies, Inc., in Cambridge, MA. Other common but less serious side effects include fever, headache and joint pain.

Review Date: 11/7/2011 Reviewed By: Neil K. Kaneshiro, MD, MHA, Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. Follows rigorous standards of quality and accountability. A.D.A.M. Is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. Is also a founding member of Hi-Ethics and subscribes to the principles of Health on the Net Foundation (www.hon.ch).
A.D.A.M. Copyright The information given herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only - they do not constitute endorsements of those other sites. © 1997-2008 A.D.A.M., Inc. Any duplication or distribution of information contained herein is strictly prohibited.

Like this: